|
TCP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.00640051847734E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.74140000003464E-06 |
| Normal-vs-Stage2 |
2.24780000002145E-06 |
| Normal-vs-Stage3 |
1.17599996407591E-09 |
| Normal-vs-Stage4 |
2.619200E-04 |
| Stage1-vs-Stage2 |
3.259900E-02 |
| Stage1-vs-Stage3 |
5.679600E-03 |
| Stage1-vs-Stage4 |
3.220400E-01 |
| Stage2-vs-Stage3 |
9.734800E-01 |
| Stage2-vs-Stage4 |
3.337800E-01 |
| Stage3-vs-Stage4 |
2.528800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.28489996420456E-10 |
| Normal-vs-AfricanAmerican |
9.242400E-04 |
| Normal-vs-Asian |
2.998400E-02 |
| Caucasian-vs-AfricanAmerican |
9.206400E-01 |
| Caucasian-vs-Asian |
4.093000E-01 |
| AfricanAmerican-vs-Asian |
4.812800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.73620007259956E-10 |
| Normal-vs-Female |
1.10019999999267E-06 |
| Male-vs-Female |
3.829400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.002600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.73769999944895E-07 |
| Normal-vs-Age(61-80Yrs) |
8.74109995496752E-09 |
| Normal-vs-Age(81-100Yrs) |
1.376090E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.683800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.644000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.306800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.842400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.318960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.597030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.297000E-01 |
| Normal-vs-Grade 2 |
3.68960000000085E-05 |
| Normal-vs-Grade 3 |
4.66349958649914E-10 |
| Normal-vs-Grade 4 |
1.70249999986716E-07 |
| Grade 1-vs-Grade 2 |
6.165400E-01 |
| Grade 1-vs-Grade 3 |
6.356100E-02 |
| Grade 1-vs-Grade 4 |
1.817580E-02 |
| Grade 2-vs-Grade 3 |
1.051550E-02 |
| Grade 2-vs-Grade 4 |
4.835100E-03 |
| Grade 3-vs-Grade 4 |
2.438200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.780500E-03 |
| Normal-vs-ccB subtype |
5.20472553944273E-13 |
| ccA subtype-vs-ccB subtype |
9.33639999978197E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.17190000428857E-08 |
| Normal-vs-N1 |
2.845500E-02 |
| N0-vs-N1 |
3.651800E-01 |
|
|
